BR0111242A - Derivados de higromicina para o tratamento de infecções por bactérias e protozoários - Google Patents

Derivados de higromicina para o tratamento de infecções por bactérias e protozoários

Info

Publication number
BR0111242A
BR0111242A BR0111242-2A BR0111242A BR0111242A BR 0111242 A BR0111242 A BR 0111242A BR 0111242 A BR0111242 A BR 0111242A BR 0111242 A BR0111242 A BR 0111242A
Authority
BR
Brazil
Prior art keywords
compounds
formula
bacterial
treatment
infections
Prior art date
Application number
BR0111242-2A
Other languages
English (en)
Inventor
Matthew Merrill Hayward
Robert Gerald Ii Linde
Takushi Kaneko
Michael Scott Visser
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR0111242A publication Critical patent/BR0111242A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08Bridged systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/203Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"DERIVADOS DE HIGROMICINA A PARA O TRATAMENTO DE INFECçõES POR BACTéRIAS E PROTOZOáRIOS". Esta invenção refere-se a compostos com a fórmula e a sais, pró-drogas e solvatos farmaceuticamente aceitáveis dos mesmos, em que R^ 1^, R^ 2^, R^ 3^ e R^ 10^ são conforme aqui definido. Os compostos de fórmula 1 são agentes antibacterianos e antiprotozoários que podem ser utilizados para tratarem várias infecções bacterianas e por protozoários e distúrbios relacionadas com tais infecções. A invenção refere-se também a composições farmacêuticas contendo os compostos de fórmula 1 e a métodos de tratamento de infecções bacterianas e por protozoários por administração dos compostos de fórmula 1.
BR0111242-2A 2000-06-02 2001-05-25 Derivados de higromicina para o tratamento de infecções por bactérias e protozoários BR0111242A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20902300P 2000-06-02 2000-06-02
PCT/IB2001/000946 WO2001092280A1 (en) 2000-06-02 2001-05-25 Hygromycin a derivatives for the treatment of bacterial and protozoal infections

Publications (1)

Publication Number Publication Date
BR0111242A true BR0111242A (pt) 2003-06-03

Family

ID=22777009

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0111242-2A BR0111242A (pt) 2000-06-02 2001-05-25 Derivados de higromicina para o tratamento de infecções por bactérias e protozoários

Country Status (31)

Country Link
US (1) US6867230B2 (pt)
EP (1) EP1287011A1 (pt)
JP (1) JP2003535100A (pt)
KR (1) KR20030010655A (pt)
CN (1) CN1432019A (pt)
AP (1) AP2002002669A0 (pt)
AR (1) AR028667A1 (pt)
AU (1) AU2001260528A1 (pt)
BG (1) BG107265A (pt)
BR (1) BR0111242A (pt)
CA (1) CA2410643A1 (pt)
CZ (1) CZ20023859A3 (pt)
EA (1) EA200201167A1 (pt)
EC (1) ECSP014093A (pt)
EE (1) EE200200671A (pt)
GT (1) GT200100099A (pt)
HU (1) HUP0302263A2 (pt)
IL (1) IL152984A0 (pt)
IS (1) IS6618A (pt)
MA (1) MA26909A1 (pt)
MX (1) MXPA02011966A (pt)
NO (1) NO20025704D0 (pt)
OA (1) OA12277A (pt)
PA (1) PA8518101A1 (pt)
PE (1) PE20020334A1 (pt)
PL (1) PL359179A1 (pt)
SK (1) SK16612002A3 (pt)
SV (1) SV2002000474A (pt)
TN (1) TNSN01080A1 (pt)
UY (1) UY26741A1 (pt)
WO (1) WO2001092280A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101087883B1 (ko) * 2002-05-16 2011-11-30 선오비온 파마슈티컬스 인코포레이티드 포유류 아난다미드 운반물질을 억제하는 아민, 및 이의사용 방법
EP3840743A4 (en) * 2018-08-20 2022-08-17 Northeastern University HYGROMYCIN A COMPOUNDS AND METHODS OF TREATING SPIROCHETE DISEASES
CU20180159A7 (es) * 2018-12-28 2020-10-20 Chengdu Olisynn Biotechnology Co Ltd Derivados de oligosacáridos sintéticos como vacuna contra la bordetella pertussis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1234567A (en) * 1915-09-14 1917-07-24 Edward J Quigley Soft collar.
US2004123A (en) * 1934-02-15 1935-06-11 Jr Robert B Loibl Pest exterminator
MA24852A1 (fr) * 1998-05-04 1999-12-31 Pfizer Prod Inc Derives d'hygromycine a et leur procede de preparation
AU762302B2 (en) * 1998-05-04 2003-06-19 Pfizer Products Inc. 2"-deoxy hygromycin derivatives
YU32601A (sh) * 1998-12-02 2004-05-12 Pfizer Products Inc. Derivati higromicina kao antibakterijski agensi
BR0015153A (pt) * 1999-10-29 2002-07-16 Pfizer Prod Inc Derivados de higromicina
US7654321B2 (en) * 2006-12-27 2010-02-02 Schlumberger Technology Corporation Formation fluid sampling apparatus and methods

Also Published As

Publication number Publication date
PA8518101A1 (es) 2002-09-17
NO20025704L (no) 2002-11-27
EP1287011A1 (en) 2003-03-05
WO2001092280A1 (en) 2001-12-06
SV2002000474A (es) 2002-07-03
NO20025704D0 (no) 2002-11-27
OA12277A (en) 2006-05-11
CA2410643A1 (en) 2001-12-06
CZ20023859A3 (cs) 2004-02-18
SK16612002A3 (sk) 2004-04-06
US20030045528A1 (en) 2003-03-06
IS6618A (is) 2002-11-14
MXPA02011966A (es) 2003-04-22
AR028667A1 (es) 2003-05-21
TNSN01080A1 (fr) 2005-11-10
PE20020334A1 (es) 2002-04-30
EE200200671A (et) 2004-08-16
JP2003535100A (ja) 2003-11-25
EA200201167A1 (ru) 2003-06-26
CN1432019A (zh) 2003-07-23
BG107265A (bg) 2003-07-31
GT200100099A (es) 2002-01-31
IL152984A0 (en) 2003-06-24
ECSP014093A (es) 2002-01-25
PL359179A1 (en) 2004-08-23
AU2001260528A1 (en) 2001-12-11
KR20030010655A (ko) 2003-02-05
US6867230B2 (en) 2005-03-15
AP2002002669A0 (en) 2002-12-31
MA26909A1 (fr) 2004-12-20
UY26741A1 (es) 2001-12-28
HUP0302263A2 (hu) 2003-10-28

Similar Documents

Publication Publication Date Title
BR9802851A (pt) Antibióticos de macrolìdeo substituìdos por c-4
BR0015911A (pt) Derivados de benzoimidazole úteis como agentes antiproliferativos
BR9916969A (pt) Antibióticos cetólidos
BR0201437A (pt) Processo para preparar derivados de 9-desoxo-9a-aza-9a-homoeritromicina a 4"-substituìdos"
UY25780A1 (es) Nuevos antibióticos macrólidos
PA8486401A1 (es) Antibioticos cetolidos carbamato y carbazato
DE60102171D1 (de) Ketolidantibiotika
NZ507452A (en) Hygromycin a derivatives
BR0111242A (pt) Derivados de higromicina para o tratamento de infecções por bactérias e protozoários
PT1167376E (pt) Antibioticos macrolidos
BR9915813A (pt) Derivados da higromicina a como agentes antibacterianos
BR9910232A (pt) Derivados de 2-desóxi-higromicina
BR0015156A (pt) Pró-drogas de higromicina a
ECSP993239A (es) Derivados de higromicina
ECSP992931A (es) Derivados de 2'' desoxi higromicina
UY26418A1 (es) Profarmacos de higromicina a
ECSP992943A (es) Derivados de higromicina a

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A,7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 DA RPI 2016 DE 25/08/2009.